A sensitive multiplex RT-qPCR assay to detect SARS-CoV-2 in respiratory samples
Halliday, A.; Morales-Aza, B.; Duale, K.; Bristol Vaccine Centre Microbiology and Molecular Laboratories, ; Lait, P.; Milligan, R.; Hutchings, S.; Pymont, H.; Vipond, B.; Muir, P.; Waterfall, C.; Coghill, J.; Carr, J.; Plested, E.; Oliver, J.; Fidler, K.; Relton, C.; Snape, M. D.; Be On The Team Investigators, ; Davidson, A. D.; Helps, C.; Finn, A.
Show abstract
We developed an in-house RT-qPCR assay for the detection of SARS-CoV-2 from different sample types. Novel primer and probe sets were designed to amplify 2 regions of the nucleocapsid (N) gene. Two dual-target multiplex assays were then evaluated for performance in detection of SARS-CoV-2 in known samples. An assay combining one novel primer pair for N (N6), a published region for the envelope protein (E) and an extraction control target (MS2), was found to have good efficiency and a low limit of detection, and to be sensitive and specific for SARS-CoV-2 in a sample set of known positive and negative clinical samples. Assay performance was maintained for the main variants of concern (Alpha, Delta, Gamma and Omicron BA.1, BA.2, BA4, JN.1). The assay was used to test for SARS-CoV-2 in throat swab samples collected in schools from teenagers in the UK as part of an observational study of two Meningococcal B Vaccines in Jan-March 2020. The low prevalence of positives identified (0.44-0.47% in two weeks of March 2020) suggests that there was minimal circulation of SARS-CoV-2 in UK schools prior to the first lockdown. The N6/E/MS2 assay has since been used to detect SARS-CoV-2 in samples from multiple studies. Continual monitoring will ensure that performance of this novel multiplex assay is maintained as novel sub-variants emerge.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection 95%
- The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population: A survey of routine laboratory RT-PCR test results from the region of Münster, Germany 93%
- Evaluation of the diagnostic accuracy and analytical sensitivity of the novel Xpert® Mpox (Cepheid®) and STANDARD™ M10 MPX/OPX (SD Biosensor) molecular point-of-care assays for the detection of Mpox virus in skin lesion swabs and upper-respiratory swab samples 93%
Similar papers in this journal
- SARS-CoV-2 testing in the community: Testing positive samples with the TaqMan SARS-CoV-2 Mutation Panel to find variants in real-time 96%
- A Simple RT-PCR Melting temperature Assay to Rapidly Screen for Widely Circulating SARS-CoV-2 Variants 96%
- SARS-CoV-2 Genome Sequencing Methods Differ In Their Ability To Detect Variants From Low Viral Load Samples 96%
Similar papers in this journal
- Rapid adaptation of established high-throughput molecular testing infrastructure for detection of monkeypoxvirus 95%
- Rapid detection of SARS-CoV-2 variants of concern identifying a cluster of B.1.1.28/P.1 variant in British Columbia, Canada 94%
- Diagnostic accuracy of three mpox lateral flow assays for antigen detection in the Democratic Republic of Congo and the United Kingdom 93%
Similar papers in this journal
- Multiplex Target-Redundant RT-LAMP for Robust Detection of SARS-CoV-2 Using Fluorescent Universal Displacement Probes 96%
- Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights 95%
- Real-time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with Variants of Concern 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.